The world's biotech hub has turned 40, with companies turning out new drugs, diagnostics and devices aimed at helping people live healthier and longer. But with issues around drug pricing and how to turn innovation into actual products, is the Bay Area biotech scene in a mid-life crisis or headed into its golden years? How can the Bay Area keep the innovation going? What breakthroughs are emerging? Where is biotech taking the Bay Area, and where is the Bay Area taking the industry? Come to the SF Business Times Bay Area Biotech Forum and explore these questions.
For additional information and to register, CLICK HERE.